Q4 2023 Holdings
Filed 2024-02-14 | 36 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rayzebio Inc | COM | 75525N107 | $250.6M | 4,030,471 | 17.2% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $237.3M | 8,493,321 | 16.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $95.2M | 3,395,606 | 6.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $84.6M | 3,882,623 | 5.8% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $69.4M | 3,424,031 | 4.8% |
| Merus N V | COM | N5749R100 | $59.1M | 2,148,214 | 4.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $58.2M | 2,563,952 | 4.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $51.1M | 2,372,714 | 3.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $50.1M | 4,092,731 | 3.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $40.9M | 2,954,902 | 2.8% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $34.7M | 7,775,760 | 2.4% |
| Hillevax Inc | COM | 43157M102 | $33.3M | 2,075,000 | 2.3% |
| Ambrx Biopharma Inc | COM | 641871108 | $29.5M | 2,070,000 | 2.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $29.2M | 4,497,117 | 2.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $28.9M | 2,173,913 | 2.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $27.5M | 4,684,167 | 1.9% |
| Celcuity Inc(CELC) | COM | 15102K100 | $27.5M | 1,885,538 | 1.9% |
| Mersana Therapeutics Inc | COM | 59045L106 | $26.3M | 11,328,000 | 1.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $25.8M | 627,788 | 1.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $24.8M | 3,225,806 | 1.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $22.8M | 495,983 | 1.6% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $22.3M | 2,428,385 | 1.5% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $20.9M | 6,250,000 | 1.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $18.4M | 10,412,872 | 1.3% |
| Savara Inc(SVRA) | COM | 805111101 | $16.5M | 3,500,000 | 1.1% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $13.5M | 2,575,593 | 0.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $10.7M | 998,570 | 0.7% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $9.6M | 927,706 | 0.7% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $7.9M | 353,626 | 0.5% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $7.6M | 1,318,327 | 0.5% |
| Acelyrin Inc | COM | 00445A100 | $7.0M | 937,113 | 0.5% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $5.8M | 250,000 | 0.4% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $4.6M | 3,422,397 | 0.3% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $3.9M | 5,147,547 | 0.3% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $1.5M | 925,048 | 0.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $1.1M | 77,042 | 0.1% |